Back by popular demand, the 2019 industry heatmap provides a high level overview of the latest developments in the European novel therapy manufacturing space across The United Kingdom, Belgium, Greece and Switzerland, among others.
With the 2018 commercialisation of prominent Autologous therapies such as KITEs Yskarta and Novartis’ Kymriah in the global market, more and more companies are beginning to move towards commercially based products. Yet despite these unquestionable industry growths, challenging issues can hinder – and even halt – groundbreaking progress in its tracks. There are still no established routes to market and with continuous changes in regulatory requirements across different global markets achieving any form of standardisation is difficult.
Download this free resource to gain valuable insights on some of the biggest challenges:
this year’s curated programme will take you through a series of sessions from
translation and collaboration to ensuring GMP compliance and optimising
scalability. This year’s forum is also your one-stop shop for:
Please note: That all fields marked with an asterisk (*) are required.